2023-08-14 12:57:00
The Eris variant has been increasingly present for several weeks.
Faced with the rise of Eris, a new variant of Covid-19 of the Omicron type, an unprecedented vaccine will arrive next month in the United Statesaccording to information published by Archyde.com this Monday, August 14.
Convince of the need for the vaccine
The agency says that “some health experts hope Americans will welcome the new dose as they would a flu shot“but remember that”vaccine demand has fallen sharply since 2021“.
Health care providers and pharmacy chains will also have to “convince the population that the threat of Covid-19 persists and still represents a danger“, pointed out to Archyde.com Ashley Kirzinger, in charge of studies at the Kaiser Family Foundation. CBS News, the three groups that will supply the new vaccine at the end of September will be Moderna, Pfizer and Novavax.
A variant “more difficult to neutralize”
On August 9, Public Health France had reported an increase in the number of emergency visits due to the Eris variant in the country, especially for children under the age of two and people over the age of 75. As a reminder, this situation is also explained by the outbreak of cases during popular events such as the Bayonne celebrations, the absence of barrier gestures and the decline in the effectiveness of the vaccine over time.
Read also :
Covid: “an epidemic resumption”, the sharp increase in the number of cases following the arrival of the Eris variant
In an interview for the magazine Science and Futurevirologist Etienne Simon-Loriere explains that the Eris variant is “more difficult for the body to neutralize“but concerning its severity, it does not report”no concern for the general population“. Eris indeed affects the most fragile or immunocompromised people.
1692026477
#Covid #Eris #variant #progresses #vaccine #September
